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Structural Basis of Caspase Inhibition by XIAP:
Differential Roles of the Linker versus
the BIR Domain
The eliciting of caspase activities represents an evolu-
tionarily conserved point of apoptotic cell death. These
novel cysteine proteases specific for aspartic residues
are the major players that disable homeostatic and re-
pair processes, halt cell cycle progression, mediate
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The importance of caspases in apoptosis necessi-
tates that these potentially dangerous enzymes are
highly regulated by both cellular and viral inhibitors. TheSummary
inhibitors of apoptosis proteins (IAPs), which have been
identified in diverse organisms, are the only known en-The inhibitor of apoptosis proteins (IAPs) represent
dogenous caspase inhibitors that effectively suppressthe only endogenous caspase inhibitors and are char-
programmed cell death. There are currently seven hu-acterized by the presence of baculoviral IAP repeats
man IAPs, including X chromosome linked IAP (XIAP),(BIRs). Here, we report the crystal structure of the
c-IAP1, c-IAP2, NAIP, Survivin, BRUCE, and ML-IAPcomplex between human caspase-7 and XIAP (BIR2
(Rothe et al., 1995; Duckett et al., 1996; Liston et al.,and the proceeding linker). The structure surprisingly
1996; Ambrosini et al., 1997; Deveraux et al., 1997;reveals that the linker is the only contacting element
Hauser et al., 1998; Vucic et al., 2000). IAPs are charac-for the caspase, while the BIR2 domain is invisible in
terized by the presence of one to three tandem baculovi-the crystal. The linker interacts with and blocks the
ral IAP repeats (BIRs) (Crook et al., 1993; Deveraux andsubstrate groove of the caspase in a backward fash-
Reed, 1999; Miller, 1999), which exhibit a structural ar-ion, distinct from substrate recognition. Structural
chitecture of classical zinc fingers as shown by struc-analyses suggest that the linker is the energetic and
tural studies (Hinds et al., 1999; Sun et al., 1999; Chanta-specificity determinant of the interaction. Further bio-
lat et al., 2000; Liu et al., 2000; Muchmore et al., 2000;chemical characterizations clearly establish that the
Verdecia et al., 2000; Wu et al., 2000).linker harbors the major energetic determinant, while
Overexpression of almost all IAPs has been shown tothe BIR2 domain serves as a regulatory element for
suppress apoptosis induced by a variety of stimuli suchcaspase binding and Smac neutralization.
as death receptor activation, growth factor withdrawal,
and cytotoxic insults (Deveraux and Reed, 1999). In vivo,
Introduction IAP expression is deregulated in many forms of human
cancers, further strengthening the role of IAPs as cell
Induction of programmed cell death or apoptosis is cru- death inhibitors and their relevance in human diseases
cial for many aspects of biological functions in multicel- (Deveraux and Reed, 1999; Hay, 2000). In addition, it
lular organisms, including maintenance of cellular ho- has been shown by genetic knockout in mice that en-
meostasis, fetal development, and immune system dogenous NAIP is required for neuronal survival in
regulation (Steller, 1995; Thompson, 1995). Failure to pathological conditions (Holcik et al., 2000). In Drosoph-
control apoptosis can lead to serious diseases that ila, IAP function is essential for cell survival (Miller, 1999;
threaten the existence of the organism. For example, Hay, 2000). However, only three mammalian IAPs, XIAP,
the downregulation of apoptosis is often associated with c-IAP1, and c-IAP2 have been shown to exhibit direct
cancer and autoimmune diseases. The upregulation of inhibitory activity toward caspases (Deveraux et al.,
apoptosis is observed in many forms of degenerative 1997; Roy et al., 1997), while other IAPs such as survivin
disorders such as Alzheimer’s disease, ischemic injury may play important roles in microtubule organization
from stroke, and post menopausal osteoporosis. During during mitosis (Uren et al., 2000).
viral infection, apoptosis is also a central combating IAPs may exploit several different mechanisms for
element, as host cells attempt to commit suicidal apo- caspase inhibition. For example, XIAP, c-IAP1, and
ptotic cell death and viruses counteract by expressing c-IAP2 are direct inhibitors of activated effector cas-
anti-apoptotic proteins. pases such as caspase-3 and caspase-7 (Deveraux et
al., 1997; Roy et al., 1997). They are also potent inhibitors
for the proteolytic activation of caspase-9, an initiator§ To whom correspondence should be addressed (haowu@med.
caspase (Deveraux et al., 1998, 1999). Some IAPs alsocornell.edu).
k These authors contributed equally to the work. contain a RING domain, which appears to act as a ubi-
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Figure 1. Overview of the XIAP/Caspase-7
Complex
(A) Schematic domain organization of XIAP.
(B) Ribbon drawings of the XIAP/caspase-7
complex, shown looking down the 2-fold axis
(left) and with the 2-fold axis horizontal (right).
The caspase-7 protomers are shown in ma-
genta and orange and the XIAP molecules
are in cyan and blue.
(C) Electrostatic surface representation of
caspase-7 and the bound worm model of
XIAP linker (cyan) and a tetra-peptide sub-
strate inhibitor (green). Selected side chains
in XIAP are shown as stick models.
(D) Stereo view of superimposed XIAP linker
and a substrate inhibitor bearing the DEVD
sequence, showing the backward binding of
the linker and the spatial overlap for competi-
tive inhibition. The chain directions for the
linker (blue arrow) and the substrate (black
arrow) are shown.
quitin ligase for the degradation of bound caspases in the crystal. A model of caspase-7 in complex with
both the linker and the BIR2 domain suggests that such(Yang et al., 2000). Therefore, IAPs put brakes on the
apoptotic process by inhibiting caspase activity and BIR2/caspase-7 interface would have been in steric
clash with crystal packing. The linker interacts with thematuration and perhaps by degrading caspases (Green,
2000). substrate groove of the caspase in a backward fashion
that is completely different from substrate recognitionIt has been shown recently that the caspase inhibitory
function of IAPs may be relieved by a newly identified and indirectly blocks the active site. Structural analyses
of the linker/caspase-7 interaction provide an explana-novel mitochondrial protein Smac/DIABLO (Du et al.,
2000; Verhagen et al., 2000). Smac is released into the tion for the mutual specificity between XIAP, c-IAP1,
and c-IAP2 and the effector caspases. Further biochemi-cytosol during apoptosis and decreases the cellular
threshold for apoptotic stimuli. It appears to be a func- cal and biophysical characterizations using GST pull-
down and surface plasmon resonance clearly showedtional homolog of the Drosophila proteins Reaper, Hid,
and Grim, which are also IAP neutralizers (Hay, 2000). that the linker harbors the major energetic determinant
for caspase binding, while the BIR2 domain per se isThe biochemical basis of Smac function relies on a direct
physical association with multiple IAPs (Chai et al., 2000; both necessary and sufficient for Smac interaction.
Therefore, the BIR2 domain acts as a regulatory ele-Du et al., 2000; Liu et al., 2000; Verhagen et al., 2000;
Wu et al., 2000). ment, which, on one hand, strengthens the linker interac-
tion for the caspase and, on the other hand, sensesPrevious biochemical dissection of XIAP showed that
a region containing its second BIR (linker-BIR2, residues the release of Smac by direct physical interaction. The
weaker affinity of BIR2 for caspases facilitates Smac124–240) is a minimal functional unit for the inhibition
of effector caspases such as caspase-3 and -7 (Taka- binding to BIR2, which makes BIR2 a convenient peeling
point for destabilizing the XIAP/caspase interaction.hashi et al., 1999). However, it is not clear how this
inhibition is achieved. To understand the molecular ba- This function of the BIR2 domain in XIAP may be general
for other BIR domains in IAP proteins and further sug-sis of XIAP function, we obtained the crystal structure
of the complex between this region of human XIAP and gests that the BIR domains may not represent signa-
tures for caspase inhibition, but rather serve as struc-human caspase-7. The structure surprisingly revealed
that the linker is the only contacting element for the tural architectures for the evolution of diverse biological
functions.caspase, while the BIR2 domain is completely invisible
Structural Basis of Caspase Inhibition by IAPs
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belief that the conserved BIR domains play dominantTable 1. Crystallographic Statistics
roles in caspase inhibition (Deveraux and Reed, 1999).
X-Ray Data However, the BIR2 domain does appear to interact with
X-ray source CHESS F1
caspase-7 in solution, as limited proteolysis of the com-Wavelength (A˚) 0.948
plex with trypsin, chymotrypsin, and subtilisin failed toTemperature (K) 100
Space group P3221 cleave off the BIR2 domain. These observations suggest
Cell dimensions (A˚) a 5 b 5 88.5, c 5 185.4 that the BIR2 domain per se may possess low affinity
Resolution (A˚) 2.4 to the caspase (see below) and the binding may be
Rsym (last shell) (%) 5.2 (33.9) replaced by favorable packing interactions in the crystal.
Completeness (last shell) (%) 99.3 (99.5)
The C-terminal end of the linker, which the BIR2 domainMolecular Replacement
is attached to, resides at the edge of a large solventResolution (A˚) 10–3.8
Correlation coefficient 48.0 channel in the crystal. This would therefore permit the
RMR (%) 40.8 flex of the unbound BIR2 domain within this solvent
Rrigid-body (Rfree) (%) 36.6 (38.1) space and hence lead to the observed crystallographic
Refinement disordering. Similar competition between low-affinity
Resolution (A˚) 20–2.4
binding interactions and crystal packing interactions hasSigma cutoff 1.5
been observed in several low-affinity TRAF2-peptideNumber of protein residues 501
Number of protein atoms 3,925 crystal structures (Park et al., 1999; Ye et al., 1999).
Number of solvent atoms 201
Number of reflections used 28,151 Structural Determinant of the
R (Rfree) (%) 22.4 (26.0) XIAP/Caspase-7 InteractionRMSD bond length (A˚) 0.009
Residues 134–150 of XIAP are visible in the complex,RMSD bond angle (8) 1.571
RMSD bond B factor (A˚2) 2.002 out of which residues 137–150 make direct contact with
RMSD angle B factor (A˚2) 3.068 the caspase. The peptide begins as an a-helical confor-
mation and switches into an extended conformation
after residue 145. The interaction buries 700 A˚2 surface
area from each of the binding partners and engages aResults
total of 154 interfacial van der Waals contacts. Most of
the atomic interactions are hydrophobic or mixed andOverview of the XIAP/Caspase-7 Complex: Backward
Binding of the Linker and Invisibility involve hydrophobic residues (Figure 2A). The footprint
of the linker interaction on caspase-7 overlaps with thatof the BIR2 Domain
Crystal structure of the complex between human cas- of a caspase substrate (Figure 2B). There are only five
intermolecular hydrogen bonds at each interface (Figurepase-7 and a functional unit of XIAP containing the BIR2
domain and the proceeding linker region (linker-BIR2, 2C). The two independent protomers of caspase-7 and
the linker peptides are highly similar, which superimposeresidues 120–260) was determined at 2.4 A˚ resolution
(Figures 1A and 1B and Table 1). The structure surpris- to rms distances of 0.35 A˚ and 0.20 A˚, respectively.
Residue D148 of XIAP appears to be a major anchor-ingly revealed that the linker contains the only con-
tacting element for the caspase, while the BIR2 domain ing point for the interaction. Among the five well-defined
intermolecular hydrogen bonds in the complex, threeis completely invisible in the crystal from either of the two
independent XIAP/caspase-7 interactions. However, an are made by D148 (Figure 2C and Table 2), while the
remaining two are made by main chain atoms of theSDS-PAGE analysis of re-dissolved crystals confirmed
the integrity of the linker-BIR2 protein in these crystals linker peptide. The side chain carboxylate of D148
makes hydrogen bonds to the Ne1 atom of residue W240(data not shown).
In the complex, the linker peptide exhibits an a 1 b and the main chain amide nitrogen of Q276 of caspase-7,
respectively. The main chain amide nitrogen of this resi-conformation and binds to the substrate groove on the
surface of caspase-7, in a manner unlike “canonical” due is also within hydrogen bonding distance to the
carbonyl oxygen of R233 of caspase-7. Even thoughsubstrate interaction in a Michaelis-Menton complex.
This is in contrast to a previous suggestion that a se- D148 situates near the S4 site, its interaction with the
caspase is quite different from the recognition of a P4quence within the linker region (148-DISD-151) binds as
a pseudo-substrate into the active site of their target Asp by the caspase. In a complex between caspase-7
and a substrate-based inhibitor bearing the P4-DEVD-caspases (Sun et al., 1999). In fact, the main chain of the
linker peptide deviates from and runs almost antiparallel P1 sequence, the P4 Asp makes three hydrogen bonds
exclusively to Q276 (Wei et al., 2000). One side chainwith the course taken by substrate-based peptide inhibi-
tors (Figures 1C and 1D). The side chains of the linker carboxyl atom of the P4 Asp makes two hydrogen bonds
with the main chain and side chain amide atoms ofpeptide that are crucial for caspase interaction do not
interact with the well-characterized S4–S1 pockets, but Q276, while the main chain amide nitrogen of the residue
interacts with the main chain carbonyl atom of Q276.simply spatially overlap with the substrate residues.
Therefore, XIAP does not directly block the active center Unlike the highly ionic nature of substrate/caspase
interactions, the remaining interactions by the linkeras a pseudo-substrate, but indirectly causes competi-
tive inhibition by overlapping with substrate binding. peptide are mostly hydrophobic (Figure 2A and Table
2). Side chains on one side of the helix including residuesThe invisibility of the BIR2 domain in the crystal sug-
gests that the linker is the major energetic determinant of A137, L141, and V146 interact tightly with a hydrophobic
patch formed by T189, Y230, W232, and F282 of cas-the XIAP/caspase interaction, in contrast to the previous
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Figure 2. Details of the XIAP/Caspase-7 Interaction
(A) The molecular footprint of XIAP on caspase-7. Magenta: footprint for residues A137, L141, and V146. Green: footprint for residues R142,
T143, and G144. Blue: footprint for residues V147–S150.
(B) The molecular footprint of a tetra-peptide inhibitor (Ac-DEVD-CHO) for comparison. Colors yellow, magenta, green, and blue are for P1–P4
residues, respectively.
(C) Hydrogen bonding interactions between the linker (yellow) and caspase-7 (gray). Side chains for T143 and V146 of XIAP are omitted for
clarity.
pase-7 at the base of the surface groove. The other side formed by the side chain of D148 suggest that this resi-
due has to be strictly conserved. For example, a D148Nof the helix, including the main chain of R142, residue
mutation may disrupt one of the hydrogen bonds as theT143, and G144, contacts the top wall of the groove at
side chain amide atom is not a good hydrogen bondresidues G83, M84, and H144 of caspase-7. The re-
acceptor and a D148E mutation may not be accommo-maining of the peptide, including residues V147, D148,
dated due to its larger size as the D148 residue is com-I149, and S150, contacts the other end of the surface
pletely buried in the complex.groove formed by caspase-7 residues R233, W240,
Regions in caspase-7 that contact the linker XIAPQ276, and S277.
peptide are largely from the L1 loop, the L3 loop, theBased on the surface area burial and specific hydro-
C-terminal tail of the large subunit, the L4 loop, thegen bonds, residues L141, V146, V147, D148, and I149
beginning of helix a4, and the L5 loop (Figure 3B andform the key structural determinant for the interaction.
Table 2). Some of these regions, such as the L1 andAmong these residues, L141, V146, and D148 are almost
the L5 loop, are highly variable structurally. Based oncompletely buried in the complex with less than 10%
surface area burial and specific hydrogen bonds, wesurface area exposure (Figure 3A and Table 2). This
suggest that residues T189, Y230, R233, W240, Q276,analysis of the structural determinant of binding is con-
and F282 are key determinants for XIAP binding. Amongsistent with previous alanine mutagenesis results on
these residues, Y230 and F282 contribute most signifi-L141, V147, D148, and I149 (Sun et al., 1999). We predict
cantly to the large patch of hydrophobic surface at thethat V146A mutation should also exhibit a strong effect
bottom of the surface groove. The side chain of Y230on caspase binding. The specific hydrogen bonds
also contributes a specific hydrogen bond to the XIAP
peptide. R233, W240, and Q276 form the hydrogen
Table 2. Surface Areas and Hydrogen Bonds in the XIAP/ bonding network that anchors the D148 residue of XIAP.
Capase-7 Complex
The Linker/Caspase-7 Interaction ExplainsSurface Area Fraction Exposure
the Mutual Specificity of a Subset of IAPXIAP Burial (A˚2) in Complex Hydrogen Bonds
Family Members for Effector CaspasesA137 42 0.21 O:NG85
The three groups of mammalian caspases definedD138 0 0.47
based on substrate specificity are represented by cas-Y139 10 0.50
L140 5 0.18 pase-1 for group I inflammation caspases, caspase-3
L141 95 0.09 and caspase-7 for group II apoptotic effector caspases,
R142 40 0.47 and caspase-8 for group III apoptotic initiator caspases
T143 56 0.06 (Nicholson, 1999). Three members of the IAP family,
G144 55 0.05
XIAP, c-IAP1, and c-IAP2 have been shown to exhibit aQ145 22 0.33
distinct specificity for effector caspases (Deveraux etV146 75 0.07 O:OhY230
al., 1997, 1998; Roy et al., 1997; Takahashi et al., 1998).V147 80 0.23
D148 105 0.04 N:OR233; Od1:NQ276; The structural basis of this mutual specificity can be
Od2:Ne1W240 explained by the sequence conservation of key residues
I149 90 0.42 at the interface between the linker of XIAP and human
S150 45 0.55
caspase-7.
Structural Basis of Caspase Inhibition by IAPs
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Figure 3. Sequence Conservation and Mutual Specificity of XIAP, c-IAP1, and c-IAP2 for Effector Caspases such as Caspase-3 and Caspase-7
(A) Sequence conservation among linker residues in XIAP, c-IAP1, and c-IAP2.
(B) Sequence conservation and variation among different caspases for residues interacting with XIAP. Secondary structure locations and
surface area burials for these residues are also shown. *, C-terminal tail of the large subunit.
Among the different caspases, structure-based se- tion with caspase-7. We generated a series of GST con-
structs that contain the linker-BIR2, the linker alone,quence comparison is possible for the four representa-
and the BIR2 domain alone, and used these GST fusiontive caspases (caspase-1, 3, 7, and 8), for which crystal
proteins for the pulldown of caspase-7 (Figure 4A).structures are available (Walker et al., 1994; Mittl et al.,
These experiments clearly showed that the linker-BIR21997; Blanchard et al., 1999, 2000; Watt et al., 1999; Wei
and the linker alone of XIAP significantly retained cas-et al., 2000). Inclusive of all the contact residues for XIAP
pase-7 after extensive washing, while the BIR2 domainin caspase-7, the corresponding residues in caspase-3
alone retained only a residual amount of caspase-7,are highly conserved (Figure 3B). In contrast, corre-
suggesting that the BIR2 domain alone possesses muchsponding residues in caspase-1 and caspase-8 are less
lower affinity to caspase-7 than the linker. In addition,conserved. In particular, residue Q276, whose main
compared to the linker alone, the linker-BIR2 appearschain amide nitrogen makes a direct hydrogen bond to
to have retained caspase-7 more stoichiometrically,the carboxylate of the XIAP anchoring residue D148, is
suggesting modest but significant energetic contribu-absent in these caspases, as the L5 loop is much shorter
tion from the BIR2 domain in the linker-BIR2 protein.than that in caspase-3 and caspase-7. Therefore, the
To quantitatively determine the differential affinitieslinker of XIAP can only interact with the effector cas-
of these regions of XIAP with caspase-7, we capturedpases. As the linker is the major structural determinant
the same GST fusion proteins onto the sensor chips byof caspase recognition (see below), this explains the
anti-GST antibodies for measurement by surface plas-structural basis of XIAP specificity.
mon resonance (SPR). As the molar quantities of theThe linker residues in XIAP can be superimposed with
GST fusion proteins on the chips are equal due to thethe corresponding linkers of c-IAP1 and c-IAP2 pro-
specific capturing procedure, their interaction strengthsceeding their BIR2 domains (Figure 3A), as also sug-
to caspase-7 can be directly obtained and compared.gested earlier (Sun et al., 1999). In particular, the anchor-
These measurements showed that the linker-BIR2 pro-ing D148 residue of XIAP is absolutely conserved in this
tein exhibits a dissociation constant of 0.5 nM with cas-superposition. Residues L141, T143, and V146, which
pase-7, and that the linker alone is 70-fold weaker, withare completely buried at the interface and important
a dissociation constant of 35 nM (Table 3). Interestingly,
for caspase interaction, are either identical or contain
however, an earlier caspase inhibition assay showed
conservative substitutions. Side chains for residues that the linker peptide was not sufficient to exert cas-
R142, V147, and I149 are not completely buried and pase inhibition at a 1 mM concentration (Sun et al., 2000),
therefore may accommodate the sequence changes in contrast to our observation. We suspect that the linker
while maintaining most of the interaction. Searching of peptide may have existed as an aggregate in the ab-
other IAPs for the presence of similar sequences did sence of GST fusion due to its significant hydrophobic
not yield any positive hits, further suggesting that not all content or in a nonproductive conformation due to an
members of the IAPs exhibit caspase inhibitory activity. intramolecular interaction involving the free termini, and
is thus unable to interact with the caspase. Therefore,
Structure-Based Biochemical Experiments both qualitative and quantitative experiments presented
Establish that the Linker Is the Major Energetic here clearly established the dominant role of the linker
Determinant of the XIAP/Caspase Interaction, and the facilitating role of the BIR2 domain in caspase
While the BIR2 Domain Plays a Facilitating Role interaction and inhibition.
Previous biochemical studies suggest that at least one
BIR domain from IAPs is required for caspase inhibition, Unlike the XIAP/Caspase Interaction, SPR
suggesting a dominant role of the BIR domains in this Measurements Reveal that the BIR2 Domain
function (Deveraux and Reed, 1999). The structural ob- Alone Determines Smac Binding
servation motivated us to systematically examine the Smac is a mitochondrial protein that gets released into
the cytosol during the initiation of apoptosis and antago-role of the linker versus the BIR2 domain in the interac-
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Figure 4. Biochemical and Biophysical Characterization of the XIAP/Caspase-7 and XIAP/Smac Interactions
(A) GST pulldown analysis of the XIAP/caspase-7 interaction. Lane 1: input caspase-7, Lanes 2–4: pulldown of caspase-7 by GST-linker-BIR2,
GST-BIR2, and GST-linker of XIAP, respectively.
(B) A representative overlay of the surface plasmon resonance sensogram of the XIAP/Smac interaction.
nizes IAP function by physical interactions with IAPs to onto the caspase to stabilize the interaction. Based on
the BIR2 domain residues that have undergone chemicalrelieve caspase inhibition (Chai et al., 2000; Du et al.,
2000; Liu et al., 2000; Verhagen et al., 2000; Wu et al., shift perturbations upon the introduction of caspase-
3, we obtained a model of the linker-BIR2/caspase-72000). Previous biochemical studies showed that Smac
interacts strongly with many BIR domain constructs interaction (Figure 5A). This was done first through man-
ual docking and then refined using molecular dynamicsfrom different IAPs. However, as these experiments
used generous domain constructs that usually contain simulations that incorporate the available chemical shift
data and limited mutagenesis data (Sun et al., 1999).significant peripheral residues beyond a BIR domain
defined either by sequence or structure, it is necessary This BIR2/caspase-7 interaction is largely independent
of the maturation state of the caspase, as shown by theto re-examine some of these experiments in light of the
potential role of peripheral or linker residues in these similar pattern of chemical shift perturbations by pro-
caspase-3 (Sun et al., 1999). The model confirmed thatprotein–protein interactions.
The same comparative binding experiments using such a complex would have been in steric clash with
a neighboring molecule in the crystal lattice for bothSPR between GST fusion XIAP fragments and caspase-7
were also performed for the interaction between XIAP independent XIAP/caspase interactions, which would
shove the BIR2 domain into the neighboring solventand Smac (Figure 4B and Table 3). The experiments
showed that the BIR2 domain alone is both necessary space in the crystal lattice.
The sequence similarity between the BIR2 and BIR3and sufficient for Smac binding (KD 5 35 nM), while the
linker does not contribute to this binding. This is shown domains of XIAP allowed us to map the interacting resi-
dues for Smac onto the surface of the BIR2 domainboth by the similar affinity of Smac to either BIR2 alone
or to linker-BIR2 of XIAP and by the lack of binding of based on a structure of the BIR3/Smac complex (Liu et
al., 2000; Wu et al., 2000) (Figure 5B). This interface,the linker to Smac. This is in contrast to the weak affinity
between BIR2 alone and caspase-7, making Smac a interestingly, overlaps with residues implicated for cas-
pase-3 binding from chemical shift measurements.much stronger competitor for BIR2 binding than cas-
pase-7. Therefore, Smac may directly compete with caspases
for XIAP binding. As the BIR2 domain per se possesses
much higher affinity for Smac than for a target caspase,The BIR2 Domain of XIAP Appears to Function
as a Regulatory Domain in Caspase Binding and Smac apparently is a highly efficient competitor for BIR2
binding. Once BIR2 is stripped off the caspase by Smacin Relieving Caspase Inhibition by Smac
BIR domains are conserved motifs of around 70 residues binding, the linker would either be insufficient to main-
tain caspase binding and inhibition, or be removed offin length that exhibit a structural architecture of classical
zinc fingers. Our structural and biochemical character- the caspase through steric hindrance from the Smac
protein.izations of the XIAP/caspase interaction established that
the linker region harbors the major energetic and speci- These observations suggest a model of caspase inhi-
bition by XIAP and perhaps other related IAPs that high-ficity determinant for caspase interaction/inhibition, and
raised the hypothesis that the BIR2 domain of XIAP lights the regulatory role of the BIR2 domain in this
functions as a regulatory element for caspase inhibition.
The interaction of XIAP with a target caspase is bipar-
Table 3. SPR Measurements of XIAP/Caspase-7 andtite, involving both the linker region and the BIR2 do-
XIAP/Smac Interactionsmain. This mode of protease inhibition by binding near
Dissociationboth the active site and an exosite bears similarity to
Protein on Chip Protein in Solution Constant (KD)the inhibition of several papain-like cysteine proteases
(Bode and Huber, 2000). During caspase binding, as the GST-linker-BIR2 (124–240) Caspase-7 0.5 nM
GST-linker (124–159) 35 nMlinker possesses higher affinity to the caspase, it is most
GST-linker-BIR2 (124–240) Smac 15 nMlikely to be the binding initiator for the interaction. Upon
GST-BIR2 (156–240) 35 nMlinker binding, the BIR2 domain, which possesses much
GST-linker (124–159) No binding
weaker affinity to the caspase, would subsequently latch
Structural Basis of Caspase Inhibition by IAPs
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Figure 5. Molecular Mechanism of Caspase Inhibition by XIAP and Other Related IAPs
(A) A model of the linker-BIR2/caspase-7 complex, obtained by manual docking and restrained molecular dynamics simulations. Only half of
a dimeric complex is shown. Magenta: caspase-7; cyan: linker-BIR2. The BIR2 domain within the complex would be in steric clash with a
neighboring molecule in the current crystal.
(B) Mapping of BIR2 residues in contact with Smac (left), based on a homologous BIR3/Smac complex (Wu et al., 2000), and in contact with
a target caspase (right), based on NMR chemical shift data (Sun et al., 1999), showing the overlap and therefore the competition of the two
interactions.
(C) A schematic model for the molecular mechanism of the interplay between a caspase, XIAP, or other related IAPs and Smac, showing the
regulatory role of the BIR2 domain.
process (Figure 5C). During caspase interaction and in- tion for the caspase. The linker interacts specifically
with the substrate binding groove of the caspase in ahibition, the BIR2 domain helps to stabilize the initial
interaction of the linker near the active site of the cas- backward manner from what is seen in a regular sub-
strate. The interaction spatially overlaps with substratepase by binding to an adjacent site. When Smac is re-
leased into the cytosol from the mitochondria during the recognition and creates competitive inhibition with cas-
pase substrates. Backward binding has been observedinitiation of apoptosis, it binds the BIR2 domain of XIAP,
among other BIR domains. As Smac possesses high for synthetic small peptide inhibitors of the cysteine
protease papain (LaLonde et al., 1998). However, thisaffinity to the BIR2 domain, this interaction would easily
compete off the binding of BIR2 to a target caspase and mode of inhibitor binding is generally rather rare and
subsequently causes the liberation of the caspase from we are not aware of any cases of such binding interac-
the grip of XIAP. Our crystal structure of the linker/cas- tions for endogenous protease inhibitors. The revelation
pase-7 interaction is likely to have captured a glimpse of the interaction of an XIAP peptide with the caspase
of one step in this process in which the BIR2 domain also raises the possibility of therapeutic intervention for
has been peeled off from the caspase, by Smac in vivo relieving IAP functions in the treatment of cancer and
and by crystal packing in the crystal. Therefore, even other proliferative diseases.
though the BIR2 domain is not the energetic determinant On the other hand, the BIR2 domain of XIAP is com-
of caspase binding, it is the major responder to Smac pletely invisible in the crystal. Our structural and bio-
regulation. In this regard, as Smac appears to interact physical analyses suggest that this domain per se pos-
with many BIR domains, this function of BIR domains sesses low affinity to the target caspase. Thus, the
may be a major role for the conservation of these do- interaction between BIR2 and the caspase in solution
mains among the IAP family members. Once Smac re- may have been competed off by packing interactions
lieves the inhibitory activity of some IAPs, the uninhib- in the crystal. This weak affinity creates a convenient
ited caspases would further amplify the pro-apoptotic peeling point for relieving the inhibition of XIAP by the
process by cleaving and perhaps degrading additional Smac protein, as Smac/BIR2 interaction possesses
IAPs (Deveraux et al., 1999). higher affinity than the caspase/BIR2 interaction. A di-
rect competition of Smac to the high-affinity caspase
binding by the linker-BIR2 or full-length XIAP would haveDiscussion
been much more difficult. Therefore, the BIR2 domain
functions as a regulatory element for caspase inhibitionGeneral Roles for BIR Domains and Linker
by being the stabilizer for caspase binding and the re-Residues in Caspase Inhibition?
sponder for Smac binding.Our crystal structure of the complex between XIAP
The current structural observation raises the question(linker-BIR2) and caspase-7 surprisingly revealed that
the linker is the major determinant of binding and inhibi- whether the differential roles of the linker versus the BIR
Cell
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D206 and residues A207-Q303) that correspond to the first matura-domain represent a general phenomenon for other IAP/
tion cleavage. The expressed protein was autoprocessed to removecaspase interactions. As shown by the sequence homol-
the short N-terminal pro-domain. The purification involves Ni-affinityogy of the XIAP linker with the linker regions of c-IAP1
chromatography, ion-exchange, and gel filtration. Human XIAP
and c-IAP2, this might be true for the inhibition of cas- linker-BIR2 (residues 120–260) was expressed as a GST fusion pro-
pase-3 and caspase-7 by these IAPs as well. The situa- tein and purified by glutathione beads. The GST tag was cleaved
by thrombin and the reaction mixture was mixed with caspase-7 fortion for caspase-9 inhibition by the BIR3 domain of XIAP
complex formation. The thus obtained XIAP/caspase-7 complexis less clear (Deveraux et al., 1999; Sun et al., 2000).
was purified from GST by glutathione beads and from excess XIAPSimilar to other dissection experiments, the definition
by gel filtration. Human Smac containing a carboxy-terminal polyhis-of the BIR3 domain used for caspase-9 inhibition is also
tidine tag was expressed and purified as described earlier (Wu et
more liberal than the BIR domain per se. In the NMR al., 2000). For biosensor experiments, GST fusion proteins of various
structure of the BIR3 domain of XIAP, an additional XIAP constructs, including GST-linker-BIR2 (residues 124–240),
GST-BIR2 (residues 156–240), and GST-linker (residues 124–159),C-terminal a helix is observed in comparison with the
were expressed and purified similarly to as described for the GST-BIR2 domain structure. Based on the mutagenesis re-
linker-BIR2 protein (residues 120–260) used for crystallization.sults, this additional helix harbors at least one crucial
residue for caspase-9 interaction (Sun et al., 2000),
Crystallization and Structure Determinationwhich may be a major determinant for this inhibition.
The complex containing XIAP (residues 120–260) and caspase-7Further structural studies of the complex would be re-
was concentrated to approximately 7 mg/ml in 20 mM Tris-HCl at
quired to determine the molecular basis of this inter- pH 8.0, 300 mM NaCl, and 5 mM DTT and crystallized with hanging
action. drop vapor diffusion using 20%–30% butanol. Diffraction data were
collected at the CHESS F1 station under cryo-protected conditions
and processed with the HKL package (Otwinowski and Minor, 1997)Linker or Peripheral Residues as Convenient
(Table 1). The structure was determined by molecular replacementEvolutionary Units?
calculations with the program REPLACE (Tong, 1993). The atomic
BIR domains present in IAPs are classical zinc fingers model used for the search was modified from a human caspase-3
that are involved in numerous protein–DNA and protein– structure (PDB code 1CP3) in which residues different from the
protein interactions. In this regard, perhaps it is not caspase-7 sequence were replaced by alanines. The rotation func-
tion gave a rather clear solution at 5.5 s in height, in comparisonsurprising to note that these domains may simply serve
with the next peak at 3.5 s. However, to ensure thoroughness ofas structural architectures for the evolution of new func-
the search, a total of 66 top rotation function grid points weretions. For example, the role of peripheral residues out-
searched for translation solutions. Summary statistics for the search
side the BIR domains has also been observed in a differ- and the rigid body refinement are shown in Table 1.
ent context other than caspase inhibition, which relates To locate the BIR2 domain in the crystal, atomic models from
to survivin, an IAP family member with a specific function both the NMR structure of the BIR2 domain (PDB code 1C9Q) and
the crystal structure of the BIR3 domain (PDB code 1G73) of XIAPin mitosis. The crystal structure of the protein, which is
were used, without producing any sensible solutions. On the otherdimeric in solution, showed that the protomer structure
hand, a difference Fourier map calculated with phases from thehas an additional long C-terminal helix beyond the BIR
human caspase-3 model, which was refined using conjugate gradi-
domain. This helix and the loop in between surprisingly ent protocol only (R 5 34.6%, Rfree 5 37.0%), showed clear electron
form a majority of the dimerization interface (Chantalat densities near the substrate binding groove for the linker of XIAP.
et al., 2000; Muchmore et al., 2000; Verdecia et al., 2000). The structure was modeled using O (Jones et al., 1991) and further
refined by the CNS program (Brunger et al., 1998). The final atomicMany conserved protein domains have been impli-
model contains residues 55–196 and 211–303 from the first cas-cated in important biological functions. An example of
pase-7 protomer, residues 58–196 and 211–303 from the secondthe significance of peripheral residues around these do-
caspase-7 protomer, and residues 134–150 for both bound XIAP
mains has been provided by the crystal structure of the linkers. Ribbon drawings and stick models were produced in the
complex between the death domains of Pelle and Tube program Setor (Evans, 1993) and surface plots were made by Grasp
(Xiao et al., 1999). Death domains are protein–protein (Nicholls et al., 1991).
interaction modules involved in death receptor signaling
in mammals. In Drosophila, the serine/threonine kinase Surface Plasmon Resonance Experiments
All surface plasmon resonance measurements were performed atPelle interacts with the adaptor protein Tube through
208C using a BIACORE 2000 equipped with a research-grade B1their death domains, which leads to the activation of
sensor chip. The immobilization buffer was 10 mM HEPES, 150 mMthe transcription factor Dorsal during embryogenesis.
NaCl, 0.005% P20, pH 7.4; the running buffer was 20 mM Tris, 150
The crystal structure of the complex surprisingly showed mM NaCl, 2 mM DTT, 0.1 mg/ml BSA, 0.05% P20, pH 7.5. The GST
that an interhelical insertion and the C-terminal tail of fusion proteins of XIAP were captured at densities of z300 RU
the Tube death domain make indispensable contacts in by anti-GST monoclonal antibody (Biacore AB, Uppsala, Sweden)
immobilized on the sensor chip surface. The surfaces of four flowthe heterodimer. Collectively, these observations sug-
cells were activated for 1 min with a 1:1 mixture of 0.1 M NHSgest that conserved domains may serve as structural
(N-hydroxy-succinimide) and 0.1 M EDC (N-ethyl-N9-3-N,N-dimethyl-scaffolds for the evolution of new functions from their
aminopropyl carbodiimide) at a flow rate of 20 ml/min. The antibody
peripheral residues. These linear peripheral sequences at a concentration of 50 mM in 10 mM sodium acetate, pH 5.0 was
are perhaps much easier to evolve than modifications immobilized at a density of z5000 RU on the four flow cell surfaces.
to a three-dimensional structure. Residual binding sites within the flow cells were blocked with a 7
min injection of 1.0 M ethanolamine at pH 8.0. Each GST construct
was captured on the surface by injecting 5 ml of the construct inExperimental Procedures
running buffer over the antibody at 5 ml/min for 1 min. Complete
regeneration of the antibody surface was accomplished by an 18 sProtein Expression and Purification
Human caspase-7 (cDNA obtained from an EST clone through the injection of glycine at pH 2.2.
To collect kinetic binding data, concentration series of the SmacGenome Systems) was produced with a carboxy-terminal polyhisti-
dine tag in E. coli by coexpressing the two fragments (residues M1- and caspase-7 in running buffer were injected over the ligand and
Structural Basis of Caspase Inhibition by IAPs
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reference flow cells at a flow rate of 50 ml/min. During each injection, (1996). A conserved family of cellular genes related to the baculovi-
rus iap gene and encoding apoptosis inhibitors. EMBO J. 15, 2685–the ligand/analyte complex was allowed to associate and dissociate
for 30 and 60 s. All response data were double referenced (Myszka, 2694.
1999), thereby correcting for bulk refractive index changes and non- Evans, S.V. (1993). SETOR: hardware-lighted three-dimensional
specific analyte binding to the sample and reference surfaces. Data solid model representations of macromolecules. J. Mol. Graph. 11,
were fit globally to a simple interaction model (A 1 B 5 AB) using 134–138.
CLAMP (Myszka and Morton, 1998).
Green, D.R. (2000). Apoptotic pathways: paper wraps stone blunts
scissors. Cell 102, 1–4.
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